Early Diagnosis of Latent Tuberculosis Reactivation due to Drug Interaction between Cobicistat and Intranasal Fluticasone

BACKGROUND: Single-tablet antiretroviral therapy is currently the first-line choice for the treatment of HIV infection. Some therapeutic regimens contain the CYP3A4 inhibitor cobicistat, which can interact with drugs undergoing hepatic first-pass metabolism, leading to unintended adverse effects. CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pineda-Reyes, Roberto, Klochko, Alena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914985/
https://www.ncbi.nlm.nih.gov/pubmed/31885960
http://dx.doi.org/10.1155/2019/8243868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914985/
https://www.ncbi.nlm.nih.gov/pubmed/31885960
http://dx.doi.org/10.1155/2019/8243868

Ejemplares similares